Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cardiac allograft vasculopathy

Weis M, von Scheidt W. Cardiac allograft vasculopathy a review. Circulation 1997 96 2069-2077. [Pg.150]

Yun JJ, Fischbein MP, Laks H, et al. Rantes production during development of cardiac allograft vasculopathy. Transplantation 2001 71(11) 1649-1656. [Pg.228]

Behrendt D, Ganz P, Eang JC. Cardiac allograft vasculopathy. Curr Opin Cardiol 2000 15 422-429. [Pg.1640]

Hunter AL, Keqner A, Mueller KJ, McManus BM, Granville DJ (2008) Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy. Am J Transplant 8 1631-1638... [Pg.902]

The overwhelming majority suffer from either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy in combination with intractable heart failure (Hosenpud et al. 1997). But there is also an increasing proportion of patients who develop cardiac allograft vasculopathy several years after HTX awaiting a second HTX (retransplantation). Finally... [Pg.12]

Eisen HJ (2004) Pathogenesis and management of cardiac allograft vasculopathy. Curr Opin Organ Transplant 9 448-452... [Pg.29]

CMV continues to be an important pathogen in heart transplantpatients (Massad 2004 Rubin 2000). Not only does CMV cause disseminated viremia, it is also a significant cause of pneumonitis, myocarditis, and GI infections including hepatitis, esophagitis, enteritis, and colitis (Rubin 2000). CMV may also play a role in provoking episodes of rejection, cardiac allograft vasculopathy and PTLD (Rubin 2000). [Pg.40]

See other pages where Cardiac allograft vasculopathy is mentioned: [Pg.1192]    [Pg.95]    [Pg.1616]    [Pg.1639]    [Pg.180]    [Pg.12]    [Pg.24]    [Pg.26]    [Pg.32]    [Pg.33]    [Pg.34]    [Pg.34]    [Pg.46]    [Pg.46]    [Pg.47]    [Pg.50]   
See also in sourсe #XX -- [ Pg.26 , Pg.34 ]



SEARCH



Allografting

© 2024 chempedia.info